EIT Receives Significant Investment for its 3D Printed Orthopedic Devices
German 3D printed orthopedic device manufacturer Emerging Implant Technologies (EIT) has just announced that it has received a significant investment from German private equity company SHS mbH. With the new funds, EIT, a pioneer in making 3D printed medical orthopedic devices, will seek to both expand its international presence, notably within the United States, and continue developing its range of innovative products.
Emerging Implant Technologies was founded in 2014 in Tuttlingen, Germany and has established itself as a reliable manufacturer of 3D printed orthopedic medical devices and implants. Using Selective Laser Melting (SLM) technologies, the young company has developed its own EIT Cellular Titanium(R) structures, which have properties such as 80% porosity and diamond pores the size of roughly 650 μm, which in mimicking trabecular bone structure, help to promote natural bone growth.
The company also offers patient specific implants, and a complete spinal fusion cage portfolio, including a Cervical Cage implant, PLIF cage, TLIF cage, and a soon to be released ALIF cage. Guntmar Eisen, founder and CEO of EIT, explains: “Our EIT Cellular Titanium implants provide the answer to current challenges in implant design and choice of materials as well the extreme cost pressure in medical technology. The additive manufacturing technology allows us to tackle existing problems with new solutions. Thus we can improve the benefits for patients without increasing costs, which is a clear competitive advantage.”
EIT’s new investment, which comes from SHS’s fourth fund generation (itself worth a total of 125 million euro), will facilitate the expansion of the 3D printed medical device manufacturer into other countries such as the United States and will allow them to develop more innovative and useful additively manufactured implants for the medical industry.
As Dr. Bernhard Schirmers, Managing Partner at SHS Gesellschaftfür Beteiligungsmanagement, explains, “EIT’s 3D-printed spine implants have already proven their superior functionality many times in practical applications, thus promoting EIT’s growth. EIT Emerging Implant Technologies’ management team is experienced and successful in the field of spine surgery. As a medical technology investor, we look forward to supporting them on their path to increased growth.”
SHS, which invests primarily in medical technology and life-science companies, is planning on making more investments and even acquisitions within the industry in the coming months. According to a press release, these additional investments will be for companies in Germany, Austria, and Switzerland. SHS’s investments are usually focused on “expansion financing, changes in shareholder structures, and successor situations.”
Author – Tess